TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/2/21 16:16 | 7/1/21 | SGTX | Sigilon Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ruffolo Robert R | MA | D | S.d | -70 | 10.36 | 0 | -7 | -100 | 0 | D | |||||||||||||||
5/24/07 18:10 | 5/22/07 | WYE | Wyeth | DE | Health | Drug | Pharmaceutical Preparations | Ruffolo Robert R | NJ | O | SVP | S.d | -7,608 | 58.33 | 0 | -130 | -35 | 241 | D | ||||||||||||||
10/26/06 17:53 | 10/24/06 | WYE | Wyeth | DE | Health | Drug | Pharmaceutical Preparations | Ruffolo Robert R | NJ | O | SVP | S.d | -7,148 | 51.22 | 0 | -140 | -100 | 0 | D | ||||||||||||||
2/14/06 15:14 | 2/10/06 | WYE | Wyeth | DE | Health | Drug | Pharmaceutical Preparations | Ruffolo Robert R | NJ | O | SVP Wyet | S | -719 | 46.17 | 0 | -16 | -100 | 0 | B |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |